Company profile for Axsome Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We aim to become a fully integrated biopharmaceutical company that develops and commercializes differentiated medicines that expand the treatment options available to caregivers and improve the lives of patients living with CNS disorders. Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders for which there are limited tre...
We aim to become a fully integrated biopharmaceutical company that develops and commercializes differentiated medicines that expand the treatment options available to caregivers and improve the lives of patients living with CNS disorders. Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders for which there are limited treatment options. Axsome's core CNS product candidate portfolio includes four clinical-stage candidates, which we are developing for six different CNS indications.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
200 Broadway, 3rd Floor New York, NY 10038
Telephone
Telephone
+1 (212) 332-3241
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/20/3191748/33090/en/Axsome-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
20 Nov 2025

https://www.globenewswire.com/news-release/2025/10/22/3170951/33090/en/Axsome-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
22 Oct 2025

https://www.globenewswire.com/news-release/2025/10/09/3164000/33090/en/Axsome-Therapeutics-Recognizes-Mental-Illness-Awareness-Week-Along-with-the-National-Advocacy-Community.html

GLOBENEWSWIRE
09 Oct 2025

https://www.globenewswire.com/news-release/2025/10/07/3162347/33090/en/Axsome-Therapeutics-to-Report-Third-Quarter-2025-Financial-Results-on-November-3.html

GLOBENEWSWIRE
07 Oct 2025

https://www.globenewswire.com/news-release/2025/09/17/3151496/33090/en/Axsome-Therapeutics-Highlights-Data-Across-Its-Leading-Neuroscience-Pipeline-at-Psych-Congress-2025.html

GLOBENEWSWIRE
17 Sep 2025

https://www.globenewswire.com/news-release/2025/08/27/3139860/33090/en/Axsome-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
27 Aug 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty